Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Payables (2016 - 2025)

Avricore Health has reported Payables over the past 12 years, most recently at -$112705.2 for Q4 2025.

  • Quarterly Payables fell 147.59% to -$112705.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$112705.2 through Dec 2025, down 147.59% year-over-year, with the annual reading at -$112490.7 for FY2025, 146.56% down from the prior year.
  • Payables was -$112705.2 for Q4 2025 at Avricore Health, up from -$214307.9 in the prior quarter.
  • Over five years, Payables peaked at $236815.1 in Q4 2024 and troughed at -$214307.9 in Q3 2025.
  • The 5-year median for Payables is $33489.1 (2022), against an average of $34367.5.
  • Year-over-year, Payables surged 544.61% in 2022 and then plummeted 4201.4% in 2024.
  • A 5-year view of Payables shows it stood at -$55209.8 in 2021, then surged by 458.17% to $197742.9 in 2022, then crashed by 34.5% to $129517.0 in 2023, then surged by 82.84% to $236815.1 in 2024, then plummeted by 147.59% to -$112705.2 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Payables are -$112705.2 (Q4 2025), -$214307.9 (Q3 2025), and $33592.8 (Q2 2025).